Printer Friendly

Browse Analgesics topic

Product development subtopic

Articles

1-62 out of 62 article(s)
Title Author Type Date Words
Baudax Bio announces publication of Phase IIIb data on ANJESO. Apr 26, 2021 474
Antibe Therapeutics expects results from Phase 2B study of pain drug ATB-346 within six weeks. May 5, 2020 355
Flexion announces preclinical data supporting development of FX301. Apr 27, 2020 405
Baudax Bio announces presentation of Phase IIIb ANJESO data. Clinical report Apr 23, 2020 719
Heron pain drug 'hits a home run' in Phase III studies, says Jefferies. Mar 19, 2018 119
Antibe Therapeutics Phase 2B GI Safety Study of Pain Drug ATB-346 Remains on Schedule. Mar 2, 2018 164
Post-turbinectomy nasal packing with Merocel versus glove finger Merocel: A prospective, randomized, controlled trial. Eta, Rani Abu; Eviatar, Ephraim; Pitaro, Jacob; Gavriel, Haim Clinical report Mar 1, 2018 2811
Daiichi Sankyo's mirogabalin demonstrates mixed results in phase three global clinical development program. Jul 4, 2017 206
IND application for clinical trial of treatment of degenerative disc disease. Jan 16, 2017 209
IND application for clinical trial of treatment of disc disease. Jan 9, 2017 209
IND application for clinical trial of treatment of disc disease. Jan 9, 2017 209
City company working on pain killing patch. May 17, 2016 358
Alkermes initiated a Phase I study of ALKS 7106, an oral, small-molecule drug candidate for the treatment of pain. The randomized, double-blind, placebo-controlled study will evaluate the safety, tolerability and pharmacokinetics of ALKS 7106 in approximately 80 healthy, male adults. Oct 1, 2014 101
AstraZeneca updates data from Phase III study of naloxegol in patients with non-cancer pain and opioid-induced constipation. Oct 15, 2013 251
AstraZeneca updates data from Phase III study of naloxegol in patients with non-cancer pain and opioid-induced constipation. Oct 15, 2013 265
Imprimis completes clinical trials of Impracor. Feb 21, 2013 129
Imprimis completes clinical trials of Impracor. Feb 21, 2013 125
Hopkins trial shows partially matched BMTs can eliminate sickle cell disease in some patients. Dec 1, 2012 136
Zalicus starts Phase I study of analgesic candidate Z160. Dec 5, 2011 149
Pharmaleads advances PL37 painkiller into Phase II trial after successful initial efficacy study. Nov 25, 2011 502
Nektar reports encouraging Phase I data for opioid analgesic NKTR-181. Sep 22, 2011 330
Nektar reports Phase I data for opioid analgesic candidate. Jun 8, 2011 408
-Diamyd Medical publishes phase I results for cancer pain drug. Apr 11, 2011 211
-Diamyd Medical publishes phase I results for cancer pain drug. Apr 11, 2011 209
The development of oral opioid analgesia. Ball, C.; Westhorpe, R.N. Mar 1, 2011 1191
-EpiCept unveils positive phase IIb data with NP-1. Feb 7, 2011 239
-EpiCept unveils positive phase IIb data with NP-1. Feb 7, 2011 240
-Diamyd Medical doses first patient in phase II study with cancer pain drug. Clinical report Jan 17, 2011 196
Diamyd doses first patient in Phase II study of N2 Enkephalin. Clinical report Jan 17, 2011 232
Diamyd doses first patient in Phase II study of N2 Enkephalin. Clinical report Jan 17, 2011 233
Diamyd initiates Phase II study of NP2 Enkephalin in cancer pain. Jan 17, 2011 269
-Diamyd Medical doses first patient in phase II study with cancer pain drug. Clinical report Jan 17, 2011 195
EpiCept's partner starts Phase IIB trial of Azixa in glioblastoma multiforme. Dec 28, 2010 234
-Diamyd Medical unveils positive phase I data with chronic pain drug. Oct 19, 2010 267
Nektar reports preclinical data for mu-opioid analgesic NKTR-181. Oct 18, 2010 287
PriCara says Expert Opinion on Pharmacotherapy publishes Phase III tapentadol data. Sep 28, 2010 136
Progenics completes treatment phase of Phase III study of RELISTOR. Sep 23, 2010 203
Orexo says Japanese partner pulls out application for cancer pain product, to make more trials. Aug 27, 2010 180
Cara Therapeutics announces Phase II data for peripheral analgesic in acute post-operative pain. Clinical report Feb 9, 2010 375
Pacira reports Phase III study results for EXPAREL for prolonged post operative analgesia. Clinical report Dec 2, 2009 261
Ironwood Pharmaceuticals Inc. Brief article Nov 30, 2009 124
Novartis' valturna combo gains approval: GSK pain drug gets positive Phase IIb results. Oct 1, 2009 765
Swedish Orexo says cancer drug gets positive phase III results in Japan. Clinical report Jul 24, 2009 183
Jazz Pharmaceuticals Inc. Brief article Jun 29, 2009 260
And Alpharma Inc.'s (Bridgewater NJ) powerful painkiller Embeda may not thwart drug abusers despite design features aimed at curbing misuse, agency staff said in documents released last week. Brief article Nov 17, 2008 114
Dual role: painkiller may affect brain. Maxmen, Amy Mar 15, 2008 379
Strength, form of products big factors. Brief article Jan 29, 2007 279
Suppliers simplify delivery of heat, cold treatments. Jan 29, 2007 427
CORvalen improves pain and quality of life in fibromyalgia and chronic fatigue patients. Jun 1, 2006 221
OxyContin patent dispute is sent back to trial court. Brief Article Feb 27, 2006 249
Consumers respond to convenience of medicated patches. Jan 23, 2006 386
All-natural analgesic. Brief Article Dec 1, 2005 112
Health Care Products. Oct 17, 2005 496
New River agrees with Gallo Center to reduce opioid tolerance. Jun 1, 2005 360
Synthetic marine snail toxin receives FDA approval as intrathecal analgesic. Mechcatie, Elizabeth Mar 1, 2005 438
The U.S. Food & Drug Administration (FDA) has approved the Charite Artificial Disc, a device that treats severe low back pain by replacing a damaged or worn-out spinal disc with an artificial one. Molinaro, Hope Brief Article Dec 1, 2004 105
Analgesics. Apr 19, 2004 745
Retailers find consumers are willing to trade up. Paikert, Charles Feb 16, 2004 736
Neurogen, Merck agreement for pain drugs cleared. Brief Article Feb 1, 2004 261
Modeling relief on the action of marijuana. McDonagh, Sorcha Aug 16, 2003 545
NEW KIND OF PAIN RELIEF. Jun 1, 2001 95
New version of Dentemp introduced by Majestic. Jun 23, 1997 472

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |